Last update: April 17, 2016

بيكوسولفات صوديوم

Very Low Risk for breastfeeding

Safe. Compatible.
Minimal risk for breastfeeding and infant.

Stimulant of the intestine and laxative drug through irritation of mucosa which is similar to bisacodyl.

Its low oral bioavailability with minimal intestinal absorption causes plasma levels to be very low, that explains the observed failure of excretion into breast milk (undetectable levels).
Authorized for use in infants from age one month old.

To prevent or treat constipation is essential to have a balanced and fiber-rich diet, with a lot of fluids and exercise.


Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

بيكوسولفات صوديوم is Sodium Picosulfate in Arabic.

Is written in other languages:


بيكوسولفات صوديوم belongs to this group or family:


Main tradenames from several countries containing بيكوسولفات صوديوم in its composition:


Variable Value Unit
Oral Bioavail. 5 %
Molecular weight 499 daltons
Tmax 14 hours


  1. Gharehbaghi K, Gharehbaghi DR, Wierrani F, Sliutz G. [Treatment of Chronic Functional Constipation during Pregnancy and Lactation]. Z Geburtshilfe Neonatol. 2016 Abstract
  2. Müller-Lissner S. Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments. Expert Opin Drug Metab Toxicol. 2013 Abstract
  3. Friedrich C, Richter E, Trommeshauser D, de Kruif S, van Iersel T, Mandel K, Gessner U. Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women. Drug Metab Pharmacokinet. 2011 Abstract Full text (link to original source) Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by IHAN from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM